News releases from the National Institutes of Health (NIH)
Updated: 2 hours 40 min ago
Findings helped inform Nigeria’s public health response.
Microbiome-triggered Th17 cells switch from protective to destructive; may be potential treatment targets.
ClinGen and ClinVar address major obstacles to genomic medicine.
: The inactivated recombinant vaccine candidate uses a weakened rabies virus vector.
NIH-funded research raises possibility of designer treatments for common form of pain.
Additional studies of common supplement planned.
Finding could provide the basis for drug therapies.
NIH-funded study calls into question common practice during labor.
Metabolites are made or used when the body breaks down food, drugs, or chemicals.
Three national centers to develop best practices for prevention, intervention and treatment.
NIH-funded study suggests a change in diet could mitigate increased risk for stroke.
NIH-funded study suggests specific cells and genes may be potential treatment targets.
NIH-funded study also finds the surgery more effective for weight loss than medication.
Winners work in directed evolution of enzymes and phage display of peptides and antibodies has had major impact on technology and medicine.
Eighty-nine awards will fund highly innovative, high-impact biomedical research.
Group reviewed current research and focused on specific drugs, formulations and other pharmacological factors that may affect health outcomes for pregnant women and nursing mothers.
The trans-NIH initiative will investigate critical health and quality-of-life needs for individuals with Down syndrome.
National repository aims to improve rehabilitation and quality of life for people who have lost a limb.
The 2018 Nobel Prize in Physiology or Medicine has been awarded to NIH grantee James P. Allison, Ph.D., of the University of Texas, M.D. Anderson Cancer Center, Houston, Texas.
NIH-funded clinical trial compares treatments for complication of inflammatory eye disease.